LT3355915T - Panašių į šunų parvoviruso (cpv) virusinių dalelių (vlp) vakcinos ir jų panaudojimas - Google Patents

Panašių į šunų parvoviruso (cpv) virusinių dalelių (vlp) vakcinos ir jų panaudojimas

Info

Publication number: LT3355915T
Authority: LT; Lithuania
Prior art keywords: cpv; vlp; vaccines; virus; particle
Prior art date: 2015-09-29

Application number

LTEPPCT/US2016/051736T

Other languages

English (en)

Inventor

Frederic David

Zahia HANNAS-DJEBBARA

Herve Poulet

Jules Minke

Original Assignee

Boehringer Ingelheim Animal Health USA Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-09-29

Filing date

2016-09-14

Publication date

2024-01-25

2016-09-14 Application filed by Boehringer Ingelheim Animal Health USA Inc. filed Critical Boehringer Ingelheim Animal Health USA Inc.

2024-01-25 Publication of LT3355915T publication Critical patent/LT3355915T/lt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/135—Foot- and mouth-disease virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14323—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14371—Demonstrated in vivo effect
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32123—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Microbiology (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Mycology (AREA)
Epidemiology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

LTEPPCT/US2016/051736T 2015-09-29 2016-09-14 Panašių į šunų parvoviruso (cpv) virusinių dalelių (vlp) vakcinos ir jų panaudojimas LT3355915T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201562234196P	2015-09-29	2015-09-29
PCT/US2016/051736 WO2017058521A1 (en)	2015-09-29	2016-09-14	Canine parvovirus (cpv) virus-like particle (vlp) vaccines and uses thereof

Publications (1)

Publication Number	Publication Date
LT3355915T true LT3355915T (lt)	2024-01-25

Family

ID=57003591

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEPPCT/US2016/051736T LT3355915T (lt)	2015-09-29	2016-09-14	Panašių į šunų parvoviruso (cpv) virusinių dalelių (vlp) vakcinos ir jų panaudojimas

Country Status (25)

Country	Link
US (2)	US10080798B2 (lt)
EP (2)	EP3355915B1 (lt)
JP (1)	JP6818748B2 (lt)
CN (1)	CN108348594B (lt)
AR (2)	AR106026A1 (lt)
AU (1)	AU2016332037B2 (lt)
CA (1)	CA3000352A1 (lt)
CL (1)	CL2018000820A1 (lt)
CO (1)	CO2018003460A2 (lt)
DK (1)	DK3355915T5 (lt)
ES (1)	ES2974666T3 (lt)
FI (1)	FI3355915T3 (lt)
HR (1)	HRP20231630T1 (lt)
HU (1)	HUE065661T2 (lt)
LT (1)	LT3355915T (lt)
MA (1)	MA43016A (lt)
MX (1)	MX380455B (lt)
NZ (1)	NZ741875A (lt)
PL (1)	PL3355915T3 (lt)
PT (1)	PT3355915T (lt)
RS (1)	RS65084B1 (lt)
RU (1)	RU2710854C1 (lt)
SI (1)	SI3355915T1 (lt)
WO (1)	WO2017058521A1 (lt)
ZA (1)	ZA201802117B (lt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2974666T3 (es) *	2015-09-29	2024-07-01	Boehringer Ingelheim Animal Health Usa Inc	Vacunas de partículas similares a virus (VLP) del parvovirus canino (CPV) y usos de las mismas
US20200087390A1 (en)	2016-12-21	2020-03-19	Amgen Inc.	Anti-tnf alpha antibody formulations
KR20200057742A (ko)	2017-09-23	2020-05-26	베링거잉겔하임베트메디카게엠베하	파라믹소바이러스과 발현 시스템
CN108273055A (zh) *	2018-01-03	2018-07-13	复旦大学	犬细小病毒疫苗组合物及其制备方法与应用
KR102117810B1 (ko) *	2018-11-29	2020-06-02	대한민국(농림축산식품부 농림축산검역본부장)	재조합 개파보바이러스 2c 항원 단백질 및 이의 용도
CN110157687A (zh) *	2019-05-25	2019-08-23	青岛易邦生物工程有限公司	一种犬细小病毒三价亚单位疫苗
WO2021022067A2 (en) *	2019-07-30	2021-02-04	Kindred Biosciences, Inc.	Parvovirus antibodies for veterinary use
US20220226465A1 (en)	2021-01-18	2022-07-21	ConserV Bioscience	Coronavirus Immunogenic Compositions, Methods and Uses Thereof
CN114317459B (zh) *	2021-12-31	2024-02-23	长春西诺生物科技有限公司	一种犬瘟热病毒株和基于犬瘟热病毒和犬细小病毒的二联疫苗及应用
CN114957406B (zh) *	2022-05-26	2024-02-02	吉林大学	一种犬细小病毒的三价抗原和三价病毒样颗粒以及应用
CN116082467A (zh) *	2022-12-07	2023-05-09	成都大熊猫繁育研究基地	一种基于乙肝病毒c蛋白的犬瘟热重组病毒样颗粒及其疫苗
CN116376981B (zh) *	2023-04-21	2024-11-01	西北农林科技大学	一种重组犬细小病毒假病毒

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2909462A (en)	1955-12-08	1959-10-20	Bristol Myers Co	Acrylic acid polymer laxative compositions
US5505941A (en)	1981-12-24	1996-04-09	Health Research, Inc.	Recombinant avipox virus and method to induce an immune response
CA1247080A (en)	1983-03-08	1988-12-20	Commonwealth Serum Laboratories Commission	Antigenically active amino acid sequences
DE3584341D1 (de)	1984-08-24	1991-11-14	Upjohn Co	Rekombinante dna-verbindungen und expression von polypeptiden wie tpa.
US5168062A (en)	1985-01-30	1992-12-01	University Of Iowa Research Foundation	Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4968615A (en)	1985-12-18	1990-11-06	Ciba-Geigy Corporation	Deoxyribonucleic acid segment from a virus
US4963481A (en)	1985-12-18	1990-10-16	Genetics Institute Inc	Promoter system
GB2197321B (en)	1986-09-12	1990-10-03	Genentech Inc	Method and vectors for obtaining continuous production of heterologous protein in a eukaryotic host cell line
GB8717430D0 (en)	1987-07-23	1987-08-26	Celltech Ltd	Recombinant dna product
DE3743138A1 (de)	1987-12-18	1989-09-14	Mayr Christian Gmbh & Co Kg	Schleifringlose, elektromagnetische ueberlastkupplung
US4971793A (en)	1988-05-09	1990-11-20	Boyce Thompson Institute For Plant Research, Inc.	Subunit canine parvovirus vaccine
US6204044B1 (en)	1989-09-14	2001-03-20	Caroline Sarah Brown	Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
WO1992015672A1 (en)	1991-03-07	1992-09-17	Virogenetics Corporation	Genetically engineered vaccine strain
EP0826063A1 (en)	1995-04-25	1998-03-04	Vical Incorporated	Single-vial formulations of dna/lipid complexes
US5846946A (en)	1996-06-14	1998-12-08	Pasteur Merieux Serums Et Vaccins	Compositions and methods for administering Borrelia DNA
FR2751224B1 (fr)	1996-07-19	1998-11-20	Rhone Merieux	Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
FR2751225B1 (fr)	1996-07-19	1998-11-27	Rhone Merieux	Formule de vaccin polynucleotidique aviaire
FR2751229B1 (fr)	1996-07-19	1998-11-27	Rhone Merieux	Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751226B1 (fr)	1996-07-19	1998-11-27	Rhone Merieux	Formule de vaccin polynucleotidique contre les pathologies du cheval
FR2751227B1 (fr)	1996-07-19	1998-11-27	Rhone Merieux	Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
FR2751228B1 (fr)	1996-07-19	1998-11-20	Rhone Merieux	Vaccin polynucleotidique bovin pour voie intradermique
JP4111403B2 (ja)	1996-10-11	2008-07-02	ザリージェンツオブザユニバーシティーオブカリフォルニア	免疫刺激ポリヌクレオチド／免疫調節分子複合体
CA2223029A1 (en)	1997-02-12	1998-08-12	Akzo Nobel Nv	Canine parvovirus dna vaccines
DE69826124T3 (de)	1997-06-30	2007-10-11	Institut Gustave Roussy	Verabreichung der nukleinsäure in den quergestreiften muskel
FR2778858B1 (fr)	1998-05-20	2000-06-16	Oreal	Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique
FR2801607B1 (fr)	1999-11-26	2001-12-28	Merial Sas	Pneumovirus du canard et vaccins correspondants
US6852705B2 (en)	2000-01-21	2005-02-08	Merial	DNA vaccines for farm animals, in particular bovines and porcines
US7179456B2 (en)	2003-04-30	2007-02-20	Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts	Use of parvovirus for brain tumor therapy
ATE392905T1 (de)	2003-07-24	2008-05-15	Merial Ltd	Vakzin-formulierungen mit einer öl-in-wasser- emulsion
RU2015113826A (ru)	2009-10-14	2015-09-20	Дзе Борд Оф Риджентс Фор Оклахома Стейт Юниверсити	Выделение вируса, родственного парвовирусу-2 собак, от енота
JP2013529894A (ja)	2010-04-07	2013-07-25	ノバルティスアーゲー	パルボウイルスｂ１９のウイルス様粒子を生成するための方法
US20120052082A1 (en) *	2010-04-09	2012-03-01	Zetra Biologicals, LLC	Cross-protective influenza vaccine
CA2878599A1 (en) *	2012-07-24	2014-01-30	Jiansheng Yao	Vaccine compositions for prevention against dengue virus infection
CN103387996B (zh) *	2013-08-19	2015-07-15	长春西诺生物科技有限公司	犬细小病毒病毒样颗粒、其制备方法及应用
CN103409377B (zh) *	2013-08-28	2015-12-23	中国农业科学院兰州兽医研究所	犬细小病毒病毒样颗粒的制备及用途
ES2974666T3 (es) *	2015-09-29	2024-07-01	Boehringer Ingelheim Animal Health Usa Inc	Vacunas de partículas similares a virus (VLP) del parvovirus canino (CPV) y usos de las mismas

2016
- 2016-09-14 ES ES16771050T patent/ES2974666T3/es active Active
- 2016-09-14 WO PCT/US2016/051736 patent/WO2017058521A1/en not_active Ceased
- 2016-09-14 PL PL16771050.8T patent/PL3355915T3/pl unknown
- 2016-09-14 DK DK16771050.8T patent/DK3355915T5/da active
- 2016-09-14 LT LTEPPCT/US2016/051736T patent/LT3355915T/lt unknown
- 2016-09-14 SI SI201631795T patent/SI3355915T1/sl unknown
- 2016-09-14 EP EP16771050.8A patent/EP3355915B1/en active Active
- 2016-09-14 HU HUE16771050A patent/HUE065661T2/hu unknown
- 2016-09-14 FI FIEP16771050.8T patent/FI3355915T3/fi active
- 2016-09-14 EP EP23190361.8A patent/EP4286002A3/en active Pending
- 2016-09-14 US US15/265,545 patent/US10080798B2/en active Active
- 2016-09-14 MX MX2018004016A patent/MX380455B/es unknown
- 2016-09-14 NZ NZ741875A patent/NZ741875A/en unknown
- 2016-09-14 AR ARP160102803A patent/AR106026A1/es active IP Right Grant
- 2016-09-14 CA CA3000352A patent/CA3000352A1/en active Pending
- 2016-09-14 MA MA043016A patent/MA43016A/fr unknown
- 2016-09-14 AU AU2016332037A patent/AU2016332037B2/en active Active
- 2016-09-14 HR HRP20231630TT patent/HRP20231630T1/hr unknown
- 2016-09-14 JP JP2018516415A patent/JP6818748B2/ja active Active
- 2016-09-14 RS RS20240073A patent/RS65084B1/sr unknown
- 2016-09-14 PT PT167710508T patent/PT3355915T/pt unknown
- 2016-09-14 CN CN201680065340.XA patent/CN108348594B/zh active Active
- 2016-09-14 RU RU2018115796A patent/RU2710854C1/ru active
2018
- 2018-03-28 CO CONC2018/0003460A patent/CO2018003460A2/es unknown
- 2018-03-29 CL CL2018000820A patent/CL2018000820A1/es unknown
- 2018-04-03 ZA ZA2018/02117A patent/ZA201802117B/en unknown
- 2018-08-22 US US16/109,570 patent/US10537632B2/en active Active
2024
- 2024-07-03 AR ARP240101730A patent/AR133161A2/es unknown

Also Published As

Publication number	Publication date
AR133161A2 (es)	2025-09-03
AU2016332037B2 (en)	2019-06-27
CO2018003460A2 (es)	2018-06-20
CA3000352A1 (en)	2017-04-06
CN108348594B (zh)	2022-09-09
EP3355915B1 (en)	2023-11-01
DK3355915T5 (da)	2024-09-30
CN108348594A (zh)	2018-07-31
FI3355915T3 (fi)	2024-01-12
AU2016332037A1 (en)	2018-05-10
ES2974666T3 (es)	2024-07-01
CL2018000820A1 (es)	2019-03-01
ZA201802117B (en)	2019-01-30
EP4286002A3 (en)	2024-02-28
MX2018004016A (es)	2018-11-29
US10080798B2 (en)	2018-09-25
WO2017058521A1 (en)	2017-04-06
US20190000965A1 (en)	2019-01-03
HRP20231630T1 (hr)	2024-03-15
DK3355915T3 (da)	2024-01-29
MA43016A (fr)	2018-08-08
JP6818748B2 (ja)	2021-01-20
AR106026A1 (es)	2017-12-06
HUE065661T2 (hu)	2024-06-28
JP2018529718A (ja)	2018-10-11
SI3355915T1 (sl)	2024-03-29
US10537632B2 (en)	2020-01-21
EP4286002A2 (en)	2023-12-06
EP3355915A1 (en)	2018-08-08
PL3355915T3 (pl)	2024-03-25
US20170087244A1 (en)	2017-03-30
RU2710854C1 (ru)	2020-01-14
BR112018006567A2 (pt)	2018-12-11
MX380455B (es)	2025-03-12
NZ741875A (en)	2019-08-30
PT3355915T (pt)	2023-12-19
RS65084B1 (sr)	2024-02-29

Publication	Publication Date	Title
PL3355915T3 (pl)	2024-03-25	Szczepionki zawierające cząstki wirusopodobne (VLP) parwowirusa psów (CPV) i ich zastosowania
EP4004036A4 (en)	2023-11-15	VIRUS-LIKE PARTICLE VACCINES
ZA201700165B (en)	2019-06-26	Influenza virus vaccines and uses thereof
SMT202200361T1 (it)	2022-11-18	Vaccini contro virus respiratori
IL251532B (en)	2021-04-29	Modified virus-like cmv particles
SG10201913630YA (en)	2020-03-30	Zika virus vaccine
SG11201803474UA (en)	2018-05-30	Vaccines against hepatitis b virus
HUE061679T2 (hu)	2023-08-28	Zika vírus vakcina
SG11201610443WA (en)	2017-01-27	Influenza virus vaccines and uses thereof
ZA201509229B (en)	2022-03-30	Influenza virus vaccines and uses thereof
EP2968517A4 (en)	2017-02-22	Specific multivalent virus-like particle vaccines and uses thereof
IL263550A (en)	2019-01-31	Infectious bronchitis virus vaccine
GB201613191D0 (en)	2016-09-14	Zika virus vaccine
SG11201702116VA (en)	2017-04-27	Viral rna segments as immunomodulatory agents and vaccine components
GB201701573D0 (en)	2017-03-15	Virus-like particle
IL247185B (en)	2019-06-30	Tilapia virus vaccines
SG11201912454SA (en)	2020-01-30	Virus-like particles comprising zika antigen
EP3302544A4 (en)	2019-01-09	NANOPARTICLE-BASED VACCINE STRATEGY AGAINST SWINE INFLUENZA VIRUS
EP3220949A4 (en)	2018-07-11	Vaccines and diagnostics for novel porcine orthoreoviruses
EP3170509A4 (en)	2017-12-27	Vaccine containing virus-like particles
HK1254487A1 (en)	2019-07-19	Canine parvovirus (cpv) virus-like particle (vlp) vaccines and uses thereof
IL249705B (en)	2021-03-25	Influenza virus vaccines and their uses
IL249704A0 (en)	2017-02-28	Influenza virus vaccines and their uses
HK1236965A1 (en)	2018-04-06	Influenza virus vaccines and uses thereof
PT3393510T (pt)	2023-04-21	Vacina contra o vírus zika